ABSTRACT. Intracerebral inoculation of field-isolates as well as established strains of equine herpesvirus-1 (EHV-1) in suckling mice results in viral replication in neurons and glial cells and induces encephalitis. By intraperitoneal (i.p.) inoculation, no histological lesion was observed in the central nervous system (CNS) in suckling mice with the EHV-1 HH1 strain (HH1), whereas a neuroadapted variant (NHH1) produced by serial passage of HH1 in the mouse brain caused severe encephalomyelitis after i.p. inoculation. The purpose of this study was to determine the route of neuroinvasion after i.p. inoculation of NHH1 and to clarify the effects of the brain passage on viral neuroinvasion. NHH1, but not HH1, targeted splenic and pulmonary macrophages and omental fat cells on days 1 and 2 post-inoculation (p.i.). From days 1 to 3 p.i., cell-associated viremia was occurred in NHH1-infected mice, but not in HH1-infected mice. On day 4 p.i., viral antigen was detected in a few endothelial cells, perivascular glial cells and neurons in the CNS in NHH1-infected mice. The number of viral antigen-positive cells increased markedly after day 5 p.i. In contrast, no viral antigen-positive cell was detected in the CNS in HH1-infected mice, except for a few nerve cells in the thoracic cord on day 4 p.i. These results suggest that NHH1 neuroinvasion is hematogenous and is correlated with enhanced extraneural virus growth. KEY WORDS: equine herpesvirus-1, mouse, neuroinvasiveness.
In viral infections of the central nervous system (CNS), the pathologic process exhibits two properties: neuroinvasiveness and neurovirulence [12, 22] . Neuroinvasiveness is defined as the ability to penetrate the CNS following replication in tissues outside the CNS. On the other hand, neurovirulence is defined as the ability to replicate in the CNS and lead to either cell dysfunction or death.
Equine herpesvirus-1 (EHV-1), which is known to cause encephalomyelitis in horses, shows characteristic neuroinvasiveness and neurovirulence in the natural host if compared with other alphaherperviruses. Unlike other alphaherpesviruses, which invade the CNS via neural routes [1, 16] , EHV-1 spreads to the CNS by cell-associated viremia [3, 20] . Also, unlike other alphaherpesviruses showing clear evidence of neurotropism and death of infected neurons [4, 21] , EHV-1 is highly endotheliotropic [3, 23] rather than neurotropic, and causes vasculitis, thrombosis and secondary injury to the neuroparenchyma [2, 9] .
Interestingly, EHV-1 itself behaves like a neurotropic herpesvirus when it is inoculated intracerebrally into mice. Intracerebral (i.c.) inoculation of suckling mice induces encephalitis characterized by viral replication in neurons and glial cells [18, 19] . Kaschula et al. [13] passaged EHV-1 first in suckling hamster by intraperitoneal (i.p.) inoculation, then in hamsters by combining i.c. and i.p. inoculation, and finally in mouse brains. The resultant adapted virus caused encephalomyelitis in 20-day-old mice on i.c. inoculation [6] . Although these mouse models are not relevant to natural infection, neurotropic potential exposed in the models may provide a possible phenotype for studying the molecular mechanisms of alphaherpesvirus neurovirulence.
It remains unclear whether the neuroinvasiveness of EHV-1 in mice is similar to that of other alphaherpesviruses. In this study, we determined the route of viral invasion in the CNS of suckling mice after peripheral inoculation of EHV-1. Intraperitoneal inoculation was employed since the details of viral dissemination after this route of inoculation were described previously in a mouse model for herpes simplex virus type-1 (HSV-1) infection [7, 8, 15] . We also compared the neuroinvasion of prototype EHV-1 with that of a neuroadapted variant produced by multiple passages of EHV-1 in mouse brain. The effects of the brain passage on EHV-1 neuroinvasion are discussed.
MATERIALS AND METHODS

Virus passage and cell culture:
The EHV-1 HH1 strain (HH1), which was isolated from an aborted fetus in Japan [14] , was generously provided by Dr. Kirisawa, Rakuno Gakuen University, Hokkaido, Japan. Neuroadapted HH1 (NHH1) was prepared by consecutive passages of HH1 in the brains of suckling (1 to 6 days old) mice. Passage was initiated by i.c. inoculation of 4.5 × 10 6 plaque-forming units (pfu) of HH1. In each passage, brains were collected on day 3 post-inoculation (p.i.) and 33% weight/volume suspension was prepared with MEM as a diluent. The brain suspension was centrifuged and 20 µl of supernatant was used as the inoculum for each mouse in the next passage. The brain-to-brain passage was performed fifteen times until mice showed severe neurological signs. Stock viruses were grown in confluent monolayers of rabbit kidney (RK-13) cells with MEM containing 2% fetal bovine serum at a multiplicity of 0.01 pfu/cell. When cytopathic effects were almost 100% confluent, the infected cells were collected, sonicated and spun. Resultant supernatants were used as the inoculum.
Animal and experimental infection: Pregnant BALB/cA mice were purchased from Clea Japan Inc. (Tokyo, Japan). Newborn mice used in this experiment were kept with their mothers during infection. Six-day-old mice under anesthesia were inoculated with each virus. A group of 39 suckling mice was inoculated intraperitoneally with 2 × 10 6 pfu of NHH1 in 50 µl of MEM. A group of 36 suckling mice was inoculated intraperitoneally with 2 × 10 6 pfu of HH1 in 50 µl of MEM.
Histological examination: Three mice inoculated with NHH1 were anesthetized and autopsied each day from 1 to 7 days p.i. Three mice inoculated with HH1 were anesthetized and autopsied each day from 1 to 6 days p.i. The liver, spleen, kidneys, heart, lungs, thymus, mesenteric lymph nodes, adrenal glands, stomach, small and large intestine, greater omentum, brain and spinal column containing the spinal cord were collected and fixed in 2% periodate-lysinparaformaldehyde. After fixation, the spinal column was decalcified in 8% formic acid for 12 hr, and neutralized in 5% sodium sulfate for 12 hr. Tissues were embedded in paraffin wax, sectioned at 4 µm and stained with hematoxylin and eosin.
Immunohistochemistry: Immunohistochemistry was performed as previously described [17] using the labeled streptavidin-biotin (SAB) technique (Histofine SAB-PO Kit, Nichirei, Tokyo, Japan). Briefly, the sections were dewaxed, treated with 0.3% hydrogen peroxide in methanol, and blocked with 10% normal goat serum. A rabbit anti-EHV-1 polyclonal antibody (a gift from Dr. Kirisawa, Rakuno Gakuen University, Hokkaido, Japan) was added and the sections were incubated overnight at 4°C. Then the sections were washed with phosphate-buffered saline (PBS) and incubated with biotinylated goat anti-rabbit IgG for 10 min at room temperature. After further washing with PBS, the sections were incubated with streptavidin-conjugated peroxidase for 10 min at room temperature. The bound perioxidase was detected with 3,3'-diaminobenzidine. The sections were counterstained with hematoxylin. As a negative control, sections were stained without the primary antibody.
Reverse transcription-polymerase chain reaction (RT-PCR): Three mice inoculated intraperitoneally with each virus were anesthetized and autopsied every day from days 0 to 5 p.i. Total RNA was extracted from heparinized peripheral blood with Trizol-LS reagent (GIBCO BRL, Grand Island, NY, U.S.A.) according to the manufacturer's instructions. The RNA was digested with 40 units of RNase-free DNase (Roche Diagnostics, Indianapolis, Indiana, U.S.A.) for 30 min at 37°C. After digestion, cDNA synthesis was carried out with 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 125 µM dNTP, 50 ng of random hexamer (TAKARA, Shiga, Japan), 200 units of Super Script II reverse transcriptase (GIBCO BRL) and 2 µg of total RNA in a total volume of 20 µl for 50 min 42°C. The PCR primers were designed based on the EHV-1 sequence (EMBL/GenBank No. M86664) to amplify a unique region of the EHV-1 ICP0 gene. Amplification was carried out by means of a Program Temp Control System PC-800 (Astec, Aichi, Japan). PCR was performed with 0.25 µl of cDNA, 2.5 µl of GeneAmp 10 × PCR buffer II (Applied Biosystems, Foster City, California, U.S.A.; 500 mM KCl, 100 mM Tris-HCl, pH 8.3, with gelatin 0.01% w/ v), 1.5 mM MgCl 2 , 200 µM dNTPs, 2.5 unit of Ampli Taq Gold TM (Applied Biosystems), and 0.5 µM each of the primers, 5'-TTTTTGGCCGTGGATTCTGG-3' and 5'-AGT-TCTGCTTGGACGATGAG-3', in a total volume of 25 µl. The mixture was denatured at 95°C for 15 min followed by 40 cycles of amplification (94°C for 30 sec, 60°C for 30 sec, 72°C for 1 min) and 72°C for 15 min. The PCR product was analyzed by 1.5% agarose gel electrophoresis. The agarose gel was stained with ethidium bromide and visualized with a 302 nm ultraviolet transilluminator. As an internal control for RNA extraction and cDNA synthesis, PCR amplification was also performed on all cDNA samples using primers specific for the constitutively expressed cellular gene, glyceraldehydes phosphate dehydrogenase (GAPDH) (5'-ACCACCATGGAGAAGGCTGG-3' and 5'-CTCAGTG-TAGCCCAGGATGC-3').
RESULTS
Localization of virus antigen after intraperitoneal inoculation:
NHH1, but not HH1, caused encephalitis after i.p. inoculation in 6-day-old suckling mice (Tables 1, 2 ). Most of the mice inoculated with NHH1 showed no clinical signs, except for three mice that had seizures and became recumbent by day 5 p.i. To explore the sequence of events required for developing encephalitis after i.p. inoculation, we studied the distribution of the viral antigen and histological lesions in the extraneural tissues as well as in the CNS.
In peripheral organs, the distribution of the viral antigen in NHH1-infected mice (Table 1) was much more widespread than in HH1-infected mice (Table 2) . Between days 1 and 3 p.i., EHV-1 antigen in NHH1-infected mice was predominantly observed in macrophages in the spleen (Fig.  1) and lung (Fig. 2) . EHV-1 antigen was not detected in Kupffer cells but was found in a few macrophages that infiltrated the portal areas of the liver in NHH1-infected mice. During this period, many omental fat cells, endothelial cells of the spleen and a few thymic reticular cells were also positive for EHV-1 antigen in NHH1-infected mice, but not in HH1-infected mice. EHV-1 antigen was detected in cryptlining cells in the small intestine of mice infected with NHH1 after day 3 p.i. EHV-1 antigen was present in the heart and adrenal glands not only in NHH1-infected mice but also in HH1-infected mice. Antigen-positive myocar-dial cells, which were sometimes located around blood vessels, were scattered in the heart in NHH1-infected mice between days 1 and 4 p.i., and in the heart in HH1-infected mice on day 2 p.i. Antigen positive smooth muscle cells were present in a few arterioles in the heart in NHH1-infected mice on day 5 p.i. These arterioles were accompanied by perivascular mononuclear cell infiltration. In the adrenal glands, foci of antigen-positive cells located exclusively within the cortex were sometimes observed in NHH1-infected mice between days 2 and 6 p.i., and in HH1-infected mice between days 4 and 6 p.i. Most of these foci represented necrosis with infiltration of mononuclear cells.
In the CNS of mice inoculated with NHH1, no histological lesion or viral antigen was observed from 1 to 3 days p.i. Mild nonsuppurative meningoencephalomyelitis was observed in the brain stem, cerebellum and spinal cord in one of three mice on day 4 p.i. and two of three mice on day 5 p.i. In these mice, the viral antigen was mainly detected in glial cells around blood capillaries (Fig. 3) in the brain stem, cerebellum and spinal cord. A small number of perivascular neurons and a few swollen endothelial cells (Fig. 4) in the brain stem and spinal cord were also positive for EHV-1 antigen. The number of antigen-positive glial cells and neurons increased on day 5 p.i. compared to day 4 p.i. At day 6 p.i., all mice had meningoencephalomyelitis in which the lesions were localized mainly to the brain stem, cerebellum and spinal cord. Antigen-positive cells were widely distributed and thus their perivascular location became indistinct. Histological findings in NHH1-infected mice on day 7 p.i. were almost the same as on day 6 p.i., but the number of antigen-positive cells decreased markedly. In the CNS of mice inoculated with HH1, no histological lesion or viral antigen was detected through the examination, except in one of three mice on day 4 p.i., in which a very few neurons in the lateral column of the thoracic cord were positive for EHV-1 antigen.
Expression of EHV-1 mRNA in peripheral blood cells:
To determine if cell-associated viremia occurred after i.p. inoculation with EHV-1, we detected viral mRNA expressed in the peripheral blood cells of infected mice by RT-PCR. This method does not pick up cell-free viruses in blood since the EHV-1 virion contains no viral RNA. The primers we used to amplify the ICP0 gene, which is one of the early genes of EHV-1, generated a 309-bp fragment of the expected size from cDNA samples in this experiment (data not shown). Expression of the ICP0 gene was detected in the peripheral blood of NHH1-infected mice from days 1 to 3 p.i. (Table 3 ). The amplification product was not derived from contaminating viral DNA since omitting the reverse transcriptase from the cDNA synthesis reaction yielded no product (data not shown). In contrast, ICP0 RNA was not detected in the peripheral blood of HH1-infected mice.
DISCUSSION
Intraperitoneal inoculation of NHH1 induced nonsuppu- rative meningoencephalomyelitis in suckling mice. The viral antigen was present in the CNS as early as 4 days following infection. Most of the antigen-positive cells were initially perivascular glial cells around the capillary, and the capillary endothelium was occasionally positive for the viral antigen. The appearance of the viral antigen in the CNS was preceded by cell-associated viremia that occurred between days 1 and 3 p.i. These results suggest that NHH1 spreads to the mouse CNS via a hematogenous route after i.p. inoculation. In contrast to NHH1, the parental HH1 strain, caused no CNS lesion in suckling mice after i.p. inoculation. This was not due to the inability of HH1 to multiply within the CNS since the strain could cause encephalitis with neuronal and glial infection in suckling mice either by i.c. or by intranasal inoculation (data not shown). Most of the mice inoculated intraperitoneally with HH1 showed no immunoreactivity for EHV-1 in the CNS, suggesting a low incidence of neuroinvasion in HH1-infected mice. Several studies on experimental HSV-1 infection in mice revealed the mode of alphaherpesvirus neuroinvasion following i.p. inoculation. Intraperitoneal inoculation of HSV-1 (Miyama +GC strain) into mice caused infection in the adrenal glands followed by transmission to the spinal cord through the sympathetic nerves [7] . This strain also spread to the brainstem via the vagus nerves after replication in the myenteric plexus of the gut [8] . After i.p. inoculation, a neuroadapted variant of the ANG strain of HSV-1 spread to the mouse CNS via a nonhematogenous pathway and led to lethal encephalitis [15] . Johnson [11] demonstrated hematogenous neuroinvasion in suckling mice inoculated intraperitoneally with the HFEM strain of HSV-1, in which the virus propagated initially in peritoneal macrophages, Kupffer cells, splenic red pulp cells and hepatic cells, and then spread to the CNS by viremia. The viral dissemination observed in NHH1-infected mice was most similar to that in HFEM-infected mice, despite some differences in tissue tropism between these two viruses.
Although hematogenous and neural dissemination are classically considered alternative modes of neuroinvasiveness [12, 22] , a virus may spread by both routes. However, the neural dissemination of NHH1 after i.p. inoculation was unlikely for the following reasons: (1) no viral antigen was detected in dorsal root ganglia throughout the course of experiments, (2) the viral antigen initially detected in the CNS was not localized to neurons in specific nuclei such as the dorsal nucleus of the vagus nerve, but localized to the glial cells surrounding small blood vessels, and (3) viralantigen positive cells were absent in the adrenal medulla and myenteric plexus. Involvement of the olfactory pathway was also unlikely since the viral antigen was absent in the olfactory bulb and the trigeminal ganglia. On the other hand, the possibility of leaky neural spreading in HH1 infection could not be excluded since one of the three mice on day 4 p.i. had a few antigen-positive neurons in the thoracic cord.
This study also showed that the multiple brain passage of EHV-1 enhanced the viral growth in peripheral organs of mice. The paucity of cell-associated viremia in HH1-infected mice indicated the significant role of peripheral virus growth in NHH1-infected mice in inducing viremia and subsequent neuroinvasion. Certain neurotropic viruses circulate freely in the plasma rather than in association with cells [5, 10] . A very low level of cell-free viruses may have existed in the plasma of NHH1-infected mice since a small amount of viral DNA was detectable in the plasma by nested PCR amplification for the EHV-1 gB gene continuously from days 1 to 7 p.i. (data not shown). However, a similar level of EHV-1 DNA was also present continuously in the plasma of HH1-infected mice, so that the involvement of the cell-free virus in CNS invasion seemed unlikely.
In conclusion, we demonstrated the hematogenous neuroinvasion of a neuroadapted variant of EHV-1 following i.p. inoculation in suckling mice. Although this mouse model differs from natural EHV-1 infection with respect to the mode of infection and the type of cell susceptible to infection, its neuroinvasive phenotype may be of interest because EHV-1 neuroinvasion in the horse is also known to be hematogenous. 
